{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T21:12:47Z","timestamp":1788556367475,"version":"build-2803163510"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T00:00:00Z","timestamp":1513641600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs R D"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s40268-017-0224-6","type":"journal-article","created":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T01:27:14Z","timestamp":1513646834000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":64,"title":["The Risk of Thrombocytopenia During Valproic Acid Therapy: A Critical Summary of Available Clinical Data"],"prefix":"10.1007","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3359-3191","authenticated-orcid":false,"given":"Massimiliano","family":"Buoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Serati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Botturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Carlo","family":"Altamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,19]]},"reference":[{"key":"224_CR1","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/S1474-4422(15)00398-1","volume":"15","author":"T Tomson","year":"2016","unstructured":"Tomson T, Battino D, Perucca E. The remarkable story of valproic acid. Lancet Neurol. 2016;15:141.","journal-title":"Lancet Neurol."},{"key":"224_CR2","first-page":"180","volume":"20","author":"KN Fountoulakis","year":"2016","unstructured":"Fountoulakis KN, Grunze H, Vieta E, Young A, Yatham L, Blier P, Kasper S, Moeller HJ. The International College of Neuro-Psychopharmacology (CINP) treatment guidelines for Bipolar disorder in adults (CINP-BD-2017), part 3: the clinical guidelines. Int J Neuropsychopharmacol. 2016;20:180\u201395.","journal-title":"Int J Neuropsychopharmacol"},{"key":"224_CR3","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1007\/s10072-014-1701-0","volume":"35","author":"A Verrotti","year":"2014","unstructured":"Verrotti A, Scaparrotta A, Grosso S, Chiarelli F, Coppola G. Anticonvulsant drugs and hematological disease. Neurol Sci. 2014;35:983\u201393.","journal-title":"Neurol Sci."},{"key":"224_CR4","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.3171\/foc.2003.15.4.3","volume":"15","author":"A Quinones-Hinojosa","year":"2003","unstructured":"Quinones-Hinojosa A, Gulati M, Singh V, Lawton MT. Spontaneous intracerebral hemorrhage due to coagulation disorders. Neurosurg Focus. 2003;15:E3.","journal-title":"Neurosurg Focus"},{"key":"224_CR5","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0887-8994(96)00052-5","volume":"14","author":"IN Allarakhia","year":"1996","unstructured":"Allarakhia IN, Garofalo EA, Komarynski MA, Robertson PL. Valproic acid and thrombocytopenia in children: a case-controlled retrospective study. Pediatr Neurol. 1996;14:303\u20137.","journal-title":"Pediatr Neurol"},{"key":"224_CR6","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/JCP.0b013e3181db2684","volume":"30","author":"K Vasudev","year":"2010","unstructured":"Vasudev K, Keown P, Gibb I, McAllister-Williams RH. Hematological effects of valproate in psychiatric patients what are the risk factors? J Clin Psychopharmacol. 2010;30:282\u20135.","journal-title":"J Clin Psychopharmacol"},{"key":"224_CR7","first-page":"92","volume":"39","author":"MT Mart\u00ednez-Lazcano","year":"2015","unstructured":"Mart\u00ednez-Lazcano MT, Espl\u00e1-Gonz\u00e1lez S, Herraiz-Robles P, Hern\u00e1ndez-P\u00e9rez P, Chiller\u00f3n-Cuenca R, Pol-Yanguas E. Use of valproic acid in long stay units of psychiatry. Farm Hosp. 2015;39:92\u2013101.","journal-title":"Farm Hosp."},{"key":"224_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1176\/appi.ajp.158.1.128","volume":"158","author":"TJ Trannel","year":"2001","unstructured":"Trannel TJ, Ahmed I, Goebert D. Occurrence of thrombocytopenia in psychiatric patients taking valproate. Am J Psychiatry. 2001;158:128\u201330.","journal-title":"Am J Psychiatry"},{"key":"224_CR9","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1592\/phco.21.17.1325.34418","volume":"21","author":"EL Conley","year":"2001","unstructured":"Conley EL, Coley KC, Pollock BG, Dapos SV, Maxwell R, Branch RA. Prevalence and risk of thrombocytopenia with valproic acid: experience at a psychiatric teaching hospital. Pharmacotherapy. 2001;21:1325\u201330.","journal-title":"Pharmacotherapy."},{"key":"224_CR10","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1528-1167.2007.01429.x","volume":"49","author":"W Nasreddine","year":"2008","unstructured":"Nasreddine W, Beydoun A. Valproate-induced thrombocytopenia: a prospective monotherapy study. Epilepsia. 2008;49:438\u201345.","journal-title":"Epilepsia."},{"key":"224_CR11","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1212\/WNL.44.8.1418","volume":"44","author":"B Gidal","year":"1994","unstructured":"Gidal B, Spencer N, Maly M, Pitterle M, Williams E, Collins M, Jones J. Valproate-mediated disturbances of hemostasis: relationship to dose and plasma concentration. Neurology. 1994;44:1418\u201322.","journal-title":"Neurology."},{"key":"224_CR12","doi-asserted-by":"publisher","first-page":"35","DOI":"10.3109\/10401239809148816","volume":"10","author":"KR Kaufman","year":"1998","unstructured":"Kaufman KR, Gerner R. Dose-dependent valproic acid thrombocytopenia in bipolar disorder. Ann Clin Psychiatry. 1998;10:35\u20137.","journal-title":"Ann Clin Psychiatry"},{"key":"224_CR13","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1097\/01.jcp.0000088911.24613.0d","volume":"23","author":"D De Berardis","year":"2003","unstructured":"De Berardis D, Campanella D, Matera V, Gambi F, La Rovere R, Sepede G, Grimaldi MR, Pacilli AM, Salerno RM, Ferro FM. Thrombocytopenia during valproic acid treatment in young patients with new-onset bipolar disorder. J Clin Psychopharmacol. 2003;23:451\u20138.","journal-title":"J Clin Psychopharmacol"},{"key":"224_CR14","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1111\/j.1528-1157.1993.tb02139.x","volume":"34","author":"RB May","year":"1993","unstructured":"May RB, Sunder TR. Hematologic manifestations of long-term valproate therapy. Epilepsia. 1993;34:1098\u2013101.","journal-title":"Epilepsia."},{"key":"224_CR15","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00228-006-0236-6","volume":"63","author":"ML Iorio","year":"2007","unstructured":"Iorio ML, Moretti U, Colcera S, Magro L, Meneghelli I, Motola D, Rivolta AL, Salvo F, Velo GP. Use and safety profile of antiepileptic drugs in Italy. Eur J Clin Pharmacol. 2007;63:409\u201315.","journal-title":"Eur J Clin Pharmacol"},{"key":"224_CR16","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1111\/epi.12952","volume":"56","author":"ML Zighetti","year":"2015","unstructured":"Zighetti ML, Fontana G, Lussana F, Chiesa V, Vignoli A, Canevini MP, Cattaneo M. Effects of chronic administration of valproic acid to epileptic patients on coagulation tests and primary hemostasis. Epilepsia. 2015;56:e49\u201352.","journal-title":"Epilepsia."},{"key":"224_CR17","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1177\/026988110101500305","volume":"15","author":"K Vasudev","year":"2001","unstructured":"Vasudev K, Das S, Goswami U, Tayal G. Pharmacokinetics of\u00a0valproic\u00a0acid in patients with bipolar disorder. J Psychopharmacol. 2001;15:187\u201390.","journal-title":"J Psychopharmacol."}],"container-title":["Drugs in R&D"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40268-017-0224-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-017-0224-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40268-017-0224-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T04:26:32Z","timestamp":1603427192000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40268-017-0224-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,19]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["224"],"URL":"https:\/\/doi.org\/10.1007\/s40268-017-0224-6","relation":{},"ISSN":["1174-5886","1179-6901"],"issn-type":[{"value":"1174-5886","type":"print"},{"value":"1179-6901","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,19]]},"assertion":[{"value":"19 December 2017","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Prof. Altamura has served as a consultant for Merck and Astra Zeneca as well as for Sanofi, Lilly, and Pfizer speaker bureaus. Dr. Buoli has served as a consultant for Lundbeck. Drs. Serati and Botturi do not have any affiliation with or financial interest in any organization that might pose a conflict of interest with the present article. No funding sources were received for the preparation of the present manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}